explore -WSS

explore

author：leisure time 2025-09-27 16:36:26 - browse：39382

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： As AI regulations shape up, health tech startups beg for clarity

WSS

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Ukraine seeks to reclaim its role as a hub for clinical trials

Why Titanic fascinates society, still drawing tours to the wreckage

The PBM ad wars are taking over Washington, D.C.

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

FDA warns medical device makers about rise in fabricated data

leisure time

explore

entertainment

Peter Hotez and the public health issue of online harassment

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Medical records are filled with copy

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

United colonoscopy coverage change 'may cost lives,' doctors say

Titanic submersible: What a 'catastrophic implosion' means and what officials found

How one medical school became remarkably diverse

Rare Northern Lights show in US this week: Where and how to see it

Moonlake's readout produced a cash windfall. Risks remain

WATCH: Why do our ears pop?

hotspot

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

New study raises questions about niacin and heart health

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Measles policy set amid Florida outbreak alarms vaccine proponents

In 'major milestone,' FDA approves first cell therapy for solid tumors

New CMS data security rules will hurt Medicare, Medicaid research

leisure time

focus

focus

hotspot